Trilostane Production Cost Reports

The report provides a detailed analysis essential for establishing a Trilostane production plant. It encompasses all critical aspects necessary for Trilostane production, including the cost of Trilostane production, Trilostane plant cost, Trilostane production costs, and the overall Trilostane production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Trilostane production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Trilostane is a medication used to treat Cushing's syndrome, which is caused by excessive production of steroid hormones like cortisol by the adrenal glands. It blocks the enzyme 3β-hydroxysteroid dehydrogenase, which is essential for making several steroid hormones that reduce their levels in the body. It is also used for treating Conn's syndrome (excess aldosterone), postmenopausal breast cancer, and other endocrine-related conditions. It is used in veterinary medicine, especially for managing Cushing's syndrome in dogs and cats, where it helps improve symptoms like excessive thirst, urination, panting, and poor coat quality. It is administered orally as capsules and works by suppressing adrenal gland hormone production to restore balance.

The market for Trilostane is driven by its growing demand in veterinary. Its usage for treating Cushing's syndrome (hyperadrenocorticism) in dogs and cats boosts its demand. The advanced animal healthcare awareness, higher diagnosis rates via improved diagnostics, and ageing pet populations fuel market growth.

The chronic therapy needs, novel formulations, and online veterinary pharmacies, enhancing accessibility, expand its applications. The industrial Trilostane procurement is affected by the need for high-purity APIs, along with strict regulatory testing for stability/safety in oral capsules. Also, supply chain partnerships with distributors like Dechra, reimbursement in pet insurance, and opportunities in emerging markets further affect its sourcing.

Raw Material for Trilostane Production

According to the Trilostane production plant project report, the key raw materials used in the production of Trilostane include (4α,5α,17β)-4,5-Epoxyandrost-2-Eno(2,3-d)Isoxazol-17-ol (Isoxazole-epoxyandrol)- Methanol-Sodium Hydroxide-Acetic Acid.

Production Process of Trilostane

The extensive Trilostane production cost report consists of the following major industrial production process:

1. From Isoxazole-Epoxyandrol: The production of Trilostane starts by reacting Isoxazole-epoxyandrol with methanol and sodium hydroxide. The mixture is stirred, and the solution is heated at 40-45 degree Celsius for two hours to cleave the isoxazole ring. To this, acetic acid is added, and the slurry temperature is maintained at 40-45 degree Celsius. The slurry is left to stir and cool, and the solid is collected by filtration and washed with water. The product is dried in a vacuum oven to get pure Trilostane as the final product.

Trilostane forms a white to tan crystalline powder, with molecular formula C20H27NO3 and a molecular weight of 329.44 g/mol. It has a melting point of 264 degree Celsius (decomposes at 257-270 degree Celsius) and a boiling point of 467 degree Celsius. It has a density of 1.12 g/cm³ and a refractive index of 1.56. It is poorly soluble in water but is soluble in organic solvents like DMF and PBS. It is chiral with (2S,4aS,4bS,7S,9aR,11aS,11bR)-stereochemistry, light-sensitive, hygroscopic, combustible, and requires storage at 2-8 degree Celsius in dry, dark, sealed conditions away from strong oxidants. All these physical and chemical properties makes it useful as a veterinary drug.